Results 21 to 30 of about 13,355 (171)

Analysis of Measles-Mumps-Rubella (MMR) Titers of Recovered COVID-19 Patients

mBio, 2020
The measles-mumps-rubella (MMR) vaccine has been theorized to provide protection against coronavirus disease 2019 (COVID-19). Our aim was to determine whether any MMR IgG titers are inversely correlated with severity in recovered COVID-19 patients ...
Jeffrey E. Gold, William H. Baumgartl, Ramazan A. Okyay, Warren E. Licht, Paul L. Fidel, Mairi C. Noverr, Larry P. Tilley, David J. Hurley, Balázs Rada, John W. Ashford   +9 more
doaj   +1 more source

Determination of ELISA reactive mumps IgG antibodies in MMR vaccine recipients in comparison with MMR vaccine naive children: A cross sectional study [PDF]

Scripta Medica, 2021
Background/Aim: Mumps is by vaccine preventable infectious disease characterised by parotitis. In India mumps vaccines are not currently used under National Immunisation Programme (NIP).
Gupta Riya, Saxena Naveen, Gupta Parul
doaj   +1 more source

Two cases of measles after vaccination with measles mumps and rubella combined live attenuated vaccine

Shanghai yufang yixue, 2022
Measles is an acute respiratory infectious disease caused by the measles virus. It is highly infectious and easy to occur in children. It causes many serious complications such as tracheitis， otitis media and pneumonia. Since the promotion of the measles
SHEN Jinhua, HU Tajing, CHEN Wenhua, QIAN Jingxian, LU Hongmei   +4 more
doaj   +1 more source

Immunogenicity and safety of a novel MMR vaccine (live, freeze-dried) containing the Edmonston-Zagreb measles strain, the Hoshino mumps strain, and the RA 27/3 rubella strain: Results of a randomized, comparative, active controlled phase III clinical trial

Human Vaccines & Immunotherapeutics, 2017
This phase III clinical trial was conducted to evaluate the immunogenicity and safety of the single-dose and multi-dose formulations of a novel MMR vaccine (live, freeze-dried) developed by M/s Cadila Healthcare Limited, India (Cadila MMR vaccine ...
Ashwani Sood, Monjori Mitra, Himanshu Arvind Joshi, Uma Siddhartha Nayak, Prashanth Siddaiah, T. Ramesh Babu, Samarendra Mahapatro, Jayesh Sanmukhani, Gaurav Gupta, Ravindra Mittal, Reinhard Glueck   +10 more
doaj   +1 more source

MMR vaccine---worries are not justified [PDF]

Archives of Disease in Childhood, 2001
The advocates of Vaccination have exalted in the prospect of exterminating the Small Pox from the face of the earth; while its opponents have framed their tales of horror, replete with stories of novel diseases and unheard-of plagues. ... When I consider the many evidences in favour of Vaccination, which the public documents of almost every nation ...
D A, Elliman, H E, Bedford
openaire   +2 more sources

High risk of mumps infection in children who received one dose of mumps-containing vaccine: waning immunity to mumps in children aged 2-5 years from kindergartens in Jiangsu Province, China

Human Vaccines & Immunotherapeutics, 2020
Background During the period of immunization with a single-dose measles-mumps-rubella (MMR) vaccine, which has been available since 2008in China, the incidence of mumps in children aged 2–5 years has been high.
Xiang Sun, Fenyang Tang, Ying Hu, Xiuying Deng, Zhiguo Wang, Minghao Zhou, Yuanbao Liu   +6 more
doaj   +1 more source

Assessing Effectiveness of Ring Vaccination in Mitigating a Mumps Outbreak on a College Campus

International Journal of Infectious Diseases, 2022
Purpose: Mumps outbreaks continue to occur in populations that share close social networks. Ring vaccination is a strategy that focuses on vaccinating primary contacts and secondary contacts of an infected individual.
O. Soniyi, R. Huxta, A. Halbritter
doaj   +1 more source

Immunogenicity and safety of a second dose of a measles-mumps-rubella vaccine administered to healthy participants 7 years of age or older: A phase III, randomized study

Human Vaccines & Immunotherapeutics, 2018
The introduction of vaccination programs against measles, mumps, and rubella (MMR) led to significant global reduction in morbidity and mortality from these diseases.
Remon Abu-Elyazeed, William Jennings, Randall Severance, Michael Noss, Adrian Caplanusi, Michael Povey, Ouzama Henry   +6 more
doaj   +1 more source

Childhood MMR Vaccination Effectiveness Against Rubella: A Longitudinal Cohort Study

Global Pediatric Health, 2022
The vaccine effectiveness (VE) of childhood measles-mumps-rubella (MMR) vaccine to reduce childhood rubella infections in the US during the 1990s/2000s was undertaken in a retrospective longitudinal cohort study.
David A. Geier BA, Mark R. Geier MD, PhD, FACE   +1 more
doaj   +1 more source

A second dose of a measles-mumps-rubella vaccine administered to healthy four-to-six-year-old children: a phase III, observer-blind, randomized, safety and immunogenicity study comparing GSK MMR and MMR II with and without DTaP-IPV and varicella vaccines co-administration

Human Vaccines & Immunotherapeutics, 2019
In many countries, a second dose of a combined measles, mumps, and rubella (MMR) vaccine is recommended at 4–6 years of age – similarly to the booster of diphtheria, tetanus, acellular pertussis, and inactivated polio vaccine (DTaP-IPV) and the second ...
The MMR-158 Study Group
doaj   +1 more source